Results 351 to 360 of about 5,889,184 (390)
This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across ...
Frank Bray +2 more
exaly +2 more sources
This article presents global cancer statistics by world region for the year 2022 based on updated estimates from the International Agency for Research on Cancer (IARC).
Frank Bray, Hyuna Sung, Rebecca L Siegel
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Lancet, 2008
In developed countries, prostate cancer is the second most frequently diagnosed cancer, and the third most common cause of death from cancer in men. Apart from age and ethnic origin, a positive family history is probably the strongest known risk factor.
Jan-Erik, Damber, Gunnar, Aus
openaire +4 more sources
In developed countries, prostate cancer is the second most frequently diagnosed cancer, and the third most common cause of death from cancer in men. Apart from age and ethnic origin, a positive family history is probably the strongest known risk factor.
Jan-Erik, Damber, Gunnar, Aus
openaire +4 more sources
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States and compiles the most recent data on populationābased cancer occurrence.
Rebecca L Siegel, Kimberly D Miller
exaly +2 more sources
Medical Clinics of North America, 1999
Prostate cancer is the second leading cause of cancer death in men. Recommendations for screening and treatment are usually made, especially in the popular press, without regard to patient age or medical health. This article focuses on the trade-off between the benefits and side effects of screening and treatment.
L E, Hahnfeld, T D, Moon
openaire +2 more sources
Prostate cancer is the second leading cause of cancer death in men. Recommendations for screening and treatment are usually made, especially in the popular press, without regard to patient age or medical health. This article focuses on the trade-off between the benefits and side effects of screening and treatment.
L E, Hahnfeld, T D, Moon
openaire +2 more sources
Oncology Times, 2005
Prostate cancer is biologically and clinically a heterogeneous disease and its imaging evaluation will need to be tailored to the specific phases of the disease in a patient-specific, risk-adapted manner. We first present a brief overview of the natural history of prostate cancer before discussing the role of various imaging tools, including ...
openaire +3 more sources
Prostate cancer is biologically and clinically a heterogeneous disease and its imaging evaluation will need to be tailored to the specific phases of the disease in a patient-specific, risk-adapted manner. We first present a brief overview of the natural history of prostate cancer before discussing the role of various imaging tools, including ...
openaire +3 more sources
Disease-a-Month, 1991
Prostate cancer is the most common malignancy in men and the second leading cause of cancer deaths. Although the mortality rate for prostate cancer has remained unchanged for 50 years, new advances have changed classic concepts in the diagnosis and management of patients with this disease.
R A, Badalament, J R, Drago
openaire +2 more sources
Prostate cancer is the most common malignancy in men and the second leading cause of cancer deaths. Although the mortality rate for prostate cancer has remained unchanged for 50 years, new advances have changed classic concepts in the diagnosis and management of patients with this disease.
R A, Badalament, J R, Drago
openaire +2 more sources
Journal of Urology, 2007
We quantified the burden of prostate cancer in the United States by identifying trends in incidence, disease presentation, survival rates and use of health care resources, and by estimating the economic impact of the disease.The analytic methods used to generate these results were described previously.Age adjusted prostate cancer incidence rates peaked
David F, Penson, June M, Chan
openaire +2 more sources
We quantified the burden of prostate cancer in the United States by identifying trends in incidence, disease presentation, survival rates and use of health care resources, and by estimating the economic impact of the disease.The analytic methods used to generate these results were described previously.Age adjusted prostate cancer incidence rates peaked
David F, Penson, June M, Chan
openaire +2 more sources
Journal of the American Geriatrics Society, 1992
Clinically, prostate cancer (prostatic adenocarcinoma) is now the most frequently diagnosed cancer in males and the second leading cause of mortality due to cancer in the United States. However, because 75% of histologic prostate cancers remain functionally benign (will not metastasize and kill the patient), mass screening of the male population for ...
openaire +2 more sources
Clinically, prostate cancer (prostatic adenocarcinoma) is now the most frequently diagnosed cancer in males and the second leading cause of mortality due to cancer in the United States. However, because 75% of histologic prostate cancers remain functionally benign (will not metastasize and kill the patient), mass screening of the male population for ...
openaire +2 more sources
Southern Medical Journal, 1982
Prostatic cancer is a common cause of morbidity and mortality in the United States. Although many new serologic and radiologic procedures are now used in its diagnosis, the rectal examination still remains the best diagnostic test. Staging is essential for effective treatment.
openaire +2 more sources
Prostatic cancer is a common cause of morbidity and mortality in the United States. Although many new serologic and radiologic procedures are now used in its diagnosis, the rectal examination still remains the best diagnostic test. Staging is essential for effective treatment.
openaire +2 more sources

